Exclusive: Constructive Bio raises $58M for synbio work, and Nobel laureate joins board

Lei Lei Wu

News Reporter

A UK-based synthetic biology startup has brought in $58 million from private investors to fund its work engineering cell systems that can manufacture new and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Exclusive: Constructive Bio raises $58M for synbio work, and Nobel laureate joins board

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biogen, UCB declare Phase 3 lupus win and prep a second trial, but details are scant

Updated: Gene therapy maker bluebird bio cuts costs again, lays off staff

Flagship’s AI biotech Generate lands $65M upfront in Novartis deal, as first clinical readouts near

Clive Meanwell's new obesity biotech, Metsera, unveils early GLP-1 data with an eye on Phase 3 next year

House passes reauthorization of rare pediatric voucher program

PDCs vs. ADCs: A New Frontier in Targeted Cancer Therapies and the Potential for Development Partnerships

Ex­clu­sive: Con­struc­tive Bio rais­es $58M for syn­bio work, and No­bel lau­re­ate joins board

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Constructive Bio raises $58M for synbio work, and Nobel laureate joins board